About IDDI
We are an expert clinical data services and high-level strategic consulting contract research organization (CRO), providing agile clinical trials services for pharmaceutical, biotech, and medical device/diagnostic companies.
With a proven track record, IDDI provides expert Biostatistics and Clinical Data Science Services to ensure the successful execution of your clinical development program.
Passion. Science. Experience.
A passionate and experienced science-led team, committed to delivering submission-ready clinical data.
At IDDI our focus is on our people; our passion is advancing innovative biomedical research.
Meet Our Team
Commitment to Quality and Precision
“IDDI was of great benefit, particularly with respect to their responsiveness, their commitment to quality and precision, and their ability to meet our very ambitious timelines.”
Jim Taylor, CEO Oraya Therapeutics, Newark, CA, USA
How IDDI Adds Value to Your Clinical Data
Strategic-level consultancy to optimize your clinical development program even in clinical trials with complex settings.
Delivered by talented, forward-thinking and science-led professionals, who will take ownership of your needs.
Over 30 years in business ensuring continuity in your clinical development.
IDDI’s culture is scientifically driven, thanks to its founder and Chief Scientific Officer, Marc Buyse, ScD.
Expert clinical data services (EDC/RTSM/Medical Coding) providing flexible solutions for collection, standardization, analysis, documentation and reporting of your clinical data.
A Project Manager is assigned to every project. Flexibility, responsiveness, proactiveness are skills often mentioned by our customers.
Experienced contract research organization with a solid understanding of the clinical development process and breadth of therapeutic areas expertise.
Thanks to a strong collaborative approach with Academics and Key Opinion Leaders.
Resource Library
Discover our on-demand recorded webinars, podcasts, videos and scientific articles.
Fast growing company – Rewarding career. Join us and contribute to the progress of clinical research. An inspiring and exciting career with international and challenging projects is waiting for you!
Join UsSeptember 19, 2023
Good Morning Meeting | Optimizing the Transition from early to late phase trials in oncology
Subgroup Analysis in Early Drug Development
View WebinarIDDI exhibiting at BioPharma Clinical Trials Nexus 2024
Meet the IDDI team of experts at booth 6 at the 19th BioPharma Clinical Trials Nexus 2024 in Basel, Switzerland!…
IDDI at Swiss Biotech Day 2024
Meet the IDDI expert at the upcoming Swiss Biotech Day 2024 in Basel, Switzerland! IDDI’s Business Development Manager Europe – Bonaventure…
IDDI at COG New England 2024
Meet the IDDI team at booth 8 at the upcoming 2nd Annual Clinical Outsourcing Group New England! IDDI’s Director, Business…
The Challenges of Trial Supply Management
Clinical trials are expensive, and the investigational medical products (IMPs) are one of the important elements in the cost. …
IDDI Lunch & Learn in Durham, NC
SAILING SMOOTH SEAS: CHARTING THE COURSE THROUGH NEEDED ADVANCEMENTS IN SAFETY REPORTING AND NEW FDA GUIDANCE ON IDMCs IDDI and…
Lunch & Learn in San Francisco, CA
REGULATORY AND DESIGN TRENDS IN CLINICAL TRIALS IDDI and OWL Oncology Research are pleased to invite you to an exceptional…
IDDI exhibiting at COG Nordics 2024
Meet IDDI experts at COG Nordics 2024 in Copenhagen, Denmark on 9 & 10 April. Come see us at Booth…
Why do so many phase 3 trials fail?
Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement…
IDDI hosting CDISC trainings in Raleigh, NC
Join the IDDI team for a week of in-person CDISC training from April 8 to 12. IDDI is pleased to…
IDDI at the 11th Annual Clinical Trials in Oncology West Coast 2024
Meet IDDI at the Clinical Trials in Oncology West Coast Annual Conference in Burlingame, CA on April 23-24! Attending CTO…